Diabetic Nephropathy
Will be published approx. on 1. September 2027
Book
Paperback/Softback
300 pages
978-0-443-31408-7 (ISBN)
Description
Diabetic Nephropathy: Recent Therapeutic Targets for the Prevention and Management of Diabetic Complications is an essential resource on neuropathy. The book combines scientific literature and potential therapeutic solutions to approach the management of this specific diabetic health complication. It is a detailed reference on the pathogenesis of diabetes to alleviate the complications nephropathy (kidney disease) can bring. It's focus on all aspects of nephropathy, with an emphasis on molecular and biological pathways, helps guide professionals on detection and early diagnosis. The book is useful to anyone in the field, particularly those who do research investigations and practice in the area of diabetes.
More details
Series
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 235 mm
Width: 191 mm
Weight
449 gr
ISBN-13
978-0-443-31408-7 (9780443314087)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Person
Dr. Shahidul Islam, MD, Professor, PhD, Department of Biochemistry, University of KwaZulu-Natal. He is an expert in diabetes and has achieved a number of awards including the International Endocrine Society. He has over 30 years of research and teaching experience, has published in 20 international peer reviewed journals, is an "Editor-in-Chief? of the "World Journal of Diabetes?. Prof. Islam has been selected as one of the Global Top 2% researcher by Mandeley during 2019 and as one of the Global Top 0.016% researcher in the area of Experimental Diabetes Mellitus by Expert Escape during 2021. Prof. Islam has published 14 peer reviewed book chapters, more than 200 research articles in the international peer reviewed journals including 11 reviews since 2004. He has successfully supervised the research projects of over 45 Postdoctoral Fellows and students.
Content
1. Challenges in Pathogenesis, Diagnosis, and Treatment of Diabetic Nephropathy: An Update
2. Roles and Cross Talks of Macrophages in Diabetic Nephropathy
3. AMPK Allostery: A Therapeutic Target for the Management or Treatment of Diabetic Nephropathy
4. Autophagy Regulation as Therapeutic Target for Diabetic Nephropathy
5. MicroRNA and Circular RNA as New Generation Therapeutic Targets in the Management of Diabetic Nephropathy
6. Caveolin-1 in the Pathogenesis and as a Therapeutic Target for Diabetic Nephropathy
7. Exosome, a Major Extracellular Vesicle, as a Therapeutic Strategy for Diabetic Nephropathy
8. Deletion of Smad3 as a Therapeutic Target for the Prevention of Renal Fibrosis and Inflammation in Diabetic Nephropathy
9. Myokines and Mitochondrial DNA as Some Novel Therapeutic Targets for the Management of Diabetic Nephropathy
10. Activation of Nrf2 Signaling Pathway as a Therapeutic Target for the Amelioration of Diabetic Nephropathy
11. YY1 as a Novel Therapeutic Target for the Prevention of Renal Fibrosis in Diabetic Nephropathy
12. Microbubbles and Ultrasound Mediated Gene Delivery as a Novel Therapeutic Approach for the Treatment of Diabetic Nephropathy
13. Human Antigen R as a Novel Therapeutic Target for the Management of Diabetic Nephropathy
14. Farnesoid X Receptor as a Potential Therapeutic Target for the Treatment of Diabetic Kidney Disease
15. SET7, a Lysine-Specific Methyl Transferase as an Epigenetic Target for the Treatment of Diabetic Nephropathy
16. DNA Methyltransferase 1 as a Therapeutic Target for Attenuating Diabetic Nephropathy
17. Roles of Non-Coding RNA CYP4B1-PS1-001 in Regulating the Proliferation of Renal Fibrosis in Diabetic Nephropathy
18. Bioactive Pure Phytochemicals in the Management and Treatment of Diabetic Nephropathy
19. Oxidative Stress and Antioxidant Defense as a Target for the Management of Diabetic Kidney Disease
20. Roles of mTOR Inhibitors in the Management of Renal Cancer and Diabetic Kidney Disease
2. Roles and Cross Talks of Macrophages in Diabetic Nephropathy
3. AMPK Allostery: A Therapeutic Target for the Management or Treatment of Diabetic Nephropathy
4. Autophagy Regulation as Therapeutic Target for Diabetic Nephropathy
5. MicroRNA and Circular RNA as New Generation Therapeutic Targets in the Management of Diabetic Nephropathy
6. Caveolin-1 in the Pathogenesis and as a Therapeutic Target for Diabetic Nephropathy
7. Exosome, a Major Extracellular Vesicle, as a Therapeutic Strategy for Diabetic Nephropathy
8. Deletion of Smad3 as a Therapeutic Target for the Prevention of Renal Fibrosis and Inflammation in Diabetic Nephropathy
9. Myokines and Mitochondrial DNA as Some Novel Therapeutic Targets for the Management of Diabetic Nephropathy
10. Activation of Nrf2 Signaling Pathway as a Therapeutic Target for the Amelioration of Diabetic Nephropathy
11. YY1 as a Novel Therapeutic Target for the Prevention of Renal Fibrosis in Diabetic Nephropathy
12. Microbubbles and Ultrasound Mediated Gene Delivery as a Novel Therapeutic Approach for the Treatment of Diabetic Nephropathy
13. Human Antigen R as a Novel Therapeutic Target for the Management of Diabetic Nephropathy
14. Farnesoid X Receptor as a Potential Therapeutic Target for the Treatment of Diabetic Kidney Disease
15. SET7, a Lysine-Specific Methyl Transferase as an Epigenetic Target for the Treatment of Diabetic Nephropathy
16. DNA Methyltransferase 1 as a Therapeutic Target for Attenuating Diabetic Nephropathy
17. Roles of Non-Coding RNA CYP4B1-PS1-001 in Regulating the Proliferation of Renal Fibrosis in Diabetic Nephropathy
18. Bioactive Pure Phytochemicals in the Management and Treatment of Diabetic Nephropathy
19. Oxidative Stress and Antioxidant Defense as a Target for the Management of Diabetic Kidney Disease
20. Roles of mTOR Inhibitors in the Management of Renal Cancer and Diabetic Kidney Disease